These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24325699)

  • 1. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N; Schneider H
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
    Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.
    Salisbury AC; Li H; Vilain KR; Jaff MR; Schneider PA; Laird JR; Cohen DJ
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2343-2352. PubMed ID: 27884360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: aligning incentives of payer, facility, and provider: the lynchpin of providing more cost-effective care.
    Sternbergh WC
    J Endovasc Ther; 2013 Dec; 20(6):826-7. PubMed ID: 24325700
    [No Abstract]   [Full Text] [Related]  

  • 5. Prime time for drug eluting balloons in SFA interventions?
    Brodmann M
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):461-4. PubMed ID: 24941235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease.
    Werner M
    Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery.
    Kitrou P; Karnabatidis D; Katsanos K
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):569-77. PubMed ID: 27128105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
    Tepe G; Beschorner U; Ruether C; Fischer I; Pfaffinger P; Noory E; Zeller T
    J Endovasc Ther; 2015 Oct; 22(5):727-33. PubMed ID: 26250747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease.
    Fanari Z; Weintraub WS
    Cardiovasc Revasc Med; 2015; 16(7):421-5. PubMed ID: 26238266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial.
    Tepe G; Schnorr B; Albrecht T; Brechtel K; Claussen CD; Scheller B; Speck U; Zeller T
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):102-8. PubMed ID: 25616822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery.
    Sridharan ND; Boitet A; Smith K; Noorbakhsh K; Avgerinos E; Eslami MH; Makaroun M; Chaer R
    J Vasc Surg; 2018 Jan; 67(1):343-352. PubMed ID: 28958476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.